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Role of Cadmium in Carcinogenesis
with Special Reference to Cancer
of the Prostate
by Magnus Piscator*
It has been shown in animal experiments that injections of large amounts of cadmium cause
sarcoma at injection sites or testicular damage and eventually testicular tumors. Long-term
exposure with small doses of cadmium has not caused testicular or prostatic tumors in
experimental animals.
Epidemiological studies on cadmium-exposed workers have shown excess deaths due to
prostatic cancer in at least three independent investigations. All reported cases probably had
considerable exposure decades ago, but there are not enough data to permit any dose-response
calculations. The general epidemiology ofprostatic cancer was not taken into account in any of
the studies. A review ofrecent literature on epidemiology of prostatic cancer has revealed some
basic facts. Small latent prostatic cancer has been shown to be as common in areas with low
mortality from prostatic cancer as in areas with high mortality. In the U.S. the black
population has a much higher death rate from prostatic cancer than the white population.
Marital status has also been implied as a factor in the development of prostatic cancer. Black
populations in Africa have much lower death rates than blacks in the U.S., which may depend
on large differences in dietary habits. Thus racial, sexual and nutritional factors might be
important for the development of prostatic cancer, since they may influence hormonal status.
Cadmium concentrations in testes and prostate increase during heavy exposure, and it has been
shown that testosterone synthesis will decrease in cadmium-exposed animals. Excessive
exposure may interfere with the zinc/hormone relationship in the prostate, which could be a
possible explanation for the development of prostatic cancer in heavily exposed individuals.
Direct action ofcadmium on the cells is not likely, nor is it probable that low level exposure to
cadmium can be a causative factor for prostatic cancer.
Introduction
The increasing pollution by cadmium and its
present and future influence on human health has
attracted great interest during the last decade. A
large number ofreviews have appeared (1-10). The
effects of long-term low level exposure via air or
from ingestion of contaminated food have been
studied in many countries, and it is now well
established that the kidney is the critical organ
with respect to systemic effects. It has been
estimated that a cadmium concentration of about
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200 mg/kg wet weight in renal cortex might cause
tubular dysfunction. Minor controversies still exist
about the renal effects, both regarding critical
concentration and certain diagnostic procedures.
However, the possible relationship between cadmi-
um exposure and cancer is far more controversial.
In 1974, it was concluded by Friberg, et al. (1):
"The carcinogenic evidence of cadmium in human
beings is by no means conclusive, but fully moti-
vates further intensified studies in groups exposed
industrially, as well as from food and ambient air."
There were at the time a number ofreports (11-22)
on the experimental induction of cancer in animals
at injection sites or in the testes after cadmium
doses which induced severe testicular damage.
Concerning humans, there were a few reports on
107mortality in cadmium exposed workers (23-25). In
one study an increased incidence of cancer of the
prostate was reported (23).
More experimental long-term studies have since
been performed (26-28), as well as a few studies on
cancer mortality in human beings with verified or
suspected exposure to cadmium (29-31). One par-
ticular study on mortality ofcadmium workers (29)
led IARC (32) to the following conclusion: "Avail-
able studies indicate that occupational exposure to
cadmium in some form (possibly the oxide) in-
creases the risk of prostate cancer in man. In
addition, one ofthese studies suggests an increased
risk of respiratory tract cancer." After this state-
ment by IARC, data from one more study have
indicated that workers exposed to cadmium might
have an increased risk of developing cancer of the
prostate (33).
The following will focus on the possible relation-
ship between cadmium and cancer ofthe prostate.
However, it has been deemed necessary to examine
in more detail the epidemiology of cancer of the
prostate and also the physiology and biochemistry
of the prostate gland. These facts should be com-
bined with what is known about metabolism and
toxicity ofcadmium and cadmium/zinc relationships
in the body. In most papers concerned with the
relationship between cancer of the prostate and
cadmium, these factors have not been taken into
account.
Cadmium
Exposure, Metabolism and Systemic
Effects of Cadmium
Recent data show that the intake ofcadmium via
food is less than estimated earlier. Results from a
cooperative study in Japan, U.S.A and Sweden,
showed that whereas the daily intake was about 20
,ug on an average in the U.S. and Sweden, it was
morethantwice ashigh inJapan (34). Otherstudies
indicate as well that the intake is about 20 ,ug in
West European countries and the U.S. (35). There
may be large individual variation due to dietary
habits. Absorption will be influenced by the pres-
ence of other substances in the diet, e.g., calcium
and iron (1, 36) and by deficiency states. Exposure
via ambient air is in most cases low, since cadmium
concentrations in rural areas are about ng/m3 or
less, and in urban areas without major cadmium-
emitting industries, the average concentrations are
generally less than 10 ng/m3. Average concentra-
tions in air near cadmium emitting industries may
be between 0.1 and 0.5 ,ug/m3. The inhaled amount
ofcadmium within 500 m ofsuch point sources may
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be a few micrograms (1, 35). Concentrations in
working environments may vary from a few micro-
grams per cubic meter to several milligrams per
cubic meter. In many industries exposure is much
less today compared to exposure 10 to 30 years ago
(37). This is important to keep in mind when
discussing carcinogenic effects. Also important for
evaluating respiratory exposure are particle size
and type of compound. Particles forned from
cadmium oxide fume are small and deposited main-
ly in the lower part ofthe respiratory tract and the
alveoli. They are relatively easily absorbed, where-
as large particles of, e.g., cadmium sulfide, to a
large extent deposited in the upper respiratory
tract, have a relatively low solubility and absorp-
tion. Clearance of particles from the respiratory
tract to the gastrointestinal tract must also be
taken into account. Another factorcomplicating the
evaluation of respiratory exposure in industrial
workers is the secondary exposure which might
occur from smoking contaminated cigarettes or
pipe tobacco. Considerable oralexposure may occur
from contact with deposited dust. Examples ofthat
type ofexposure have recentlybeen given (38). For
nonsmoking members of the general population
intake via food is the most important. It has been
estimated (1) that a smoker may inhale a few
micrograms of cadmium every day due to the
presence of cadmium in tobacco. Several studies
have shown that smokers have considerably higher
renal concentrations ofcadmium than non-smokers
of the same age (1, 39).
Cadmium absorbed from the lungs or the gut (1)
is initially stored in the liver, where practically all
cadmium will be bound tothe metal-binding protein
metallothionein. Information about the protein and
its importance for the metabolism of zinc, copper
and cadmium is given in a recent book (40) and a
recent conference report (41). Cadmium is slowly
released from the liver and it eventually appears in
the kidneys. Since metallothionein is a low molecu-
larweight protein, itis conceivable thatitisfiltered
through the glomeruli and then reabsorbed in the
proximal part of the renal tubules. Only a minor
part of cadmium in serum appears to be bound to
metallothionein. However, a metallothionein con-
centration in plasma ofless than 100 ng/l. would be
sufficient to explain the normal accumulation of
cadmium in human kidneys. Cadmium disappears
very slowly from the kidneys as well, and it has been
estimated (1) that the half-life for cadmium in the
human body may be up to 30 years. In the
above-mentioned cooperative study (34) it was
found that among adult human beings in the U.S.
and Sweden, the renal cortex concentrations of
cadmium on an average were about 20 mg/kg wet
Environmental Health Perspectivesweight, whereas in Japan the concentrations in a
nonpolluted area were 2-3 times higher. Urinary
concentrations of cadmium were below 1 ,ug/l. in
U.S.A. and Sweden, whereas in Japan they were
close to 2 ,ug/l.
Respiratory symptoms were common among in-
dustrial workers exposed earlier to high cadmium
concentrations but present exposure in most indus-
tries seems to be below levels which may cause
pronounced symptoms. The main interest has been
focused on renal effects. It has been repeatedly
shown in studies on industrial workers (1, 42-45) as
well as the general population (46) that excessive
exposure to cadmium can cause renal tubular dys-
function. The first sign ofthistubulardysfunctionis
the excretion of low molecular weight serum pro-
teins (47, 48). Increased excretion ofsuch proteins,
e.g., 02-microglobulin and retinol-binding proteins,
isthoughttobeduetoadecreaseinthereabsorption
in the tubules of these proteins. As mentioned in
the introduction, such effects may occur at concen-
trations around 200 mg/kg wet weight in renal
cortex.
Demonstration of an increased excretion of such
proteins in urine is thus at present the best method
fordiagnosis ofearly effects ofcadmium (49, 50). In
more advanced cases ofcadmium poisoning, excre-
tion of glucose, amino acids, phosphorus and calci-
um may also be increased (1, 44, 47). The disturbed
mineral metabolism may lead to renal stones, as
seen in male Swedishworkers (1, 42), or osteomala-
cia, so called Itai-Itai disease, seen in Japanese
women (1). Studies on industrially exposed men
have shown that renal damage may appear later
after exposure has ceased. This is due to the
transfer of cadmium from liver to kidneys; after a
few years, however, there will be no further
progress, nor regress, of the disease (49).
Concerning long-term effects on other organs,
the endocrine glands are of special interest when
discussing cadmium and the prostate. Berlin and
Ullberg (51) found intheir studies on distribution of
injected cadmium in mice that the metal accumulat-
ed in the pituitary gland. Zielenska-Psuja etal. (52)
gave rats oral doses of about 5.4 and 54 mg Cd/kg
body weight for periods of 3 to 15 months. It was
found that the lower dose level caused an increase
of serum LH concentrations during the first 12
months ofexposure, compared to controls. Howev-
er, after 15 months the exposed animals had lower
LH concentrations than the controls. A higher dose
levelcaused increased LH duringthe first 6months,
but after 12 months concentrations were lowerthan
in controls. During the first 3 months a dose-
dependent reduction in serumlevels oftestosterone
was noted. Thereafter testosterone levels were
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higher in the exposed than in controls. Testes
weights increased during the first part ofthe study
in both exposure groups, but were reduced in the
high exposure group after 12 months. In a large
number of studies it has been shown that injection
ofseveral milligrams ofcadmium/kg body weight to
animals causes acute testicular necrosis and, as a
late sequela, even testicular cancer (1, 53). There
are only a few reports on testicular effects of
long-term administration of cadmium to experi-
mental animals. Piscator and Axelsson (54) and
Nordberg (55) did not find any histological changes
in testes of rabbits or mice given subcutaneous
injections of0.25mg/kg5 days aweekfor6 months.
However, Nordberg and Piscator (56) found a
decrease in protein excretion in cadmium exposed
mice before renal damage had appeared, possibly
caused by decreased testosterone production ofthe
interstitial cells in the testes. Nordberg (57) found
in mice exposed to subcutaneous injections of 0.25
mg Cd/kg 5 days a week for 6 months that there
were changes in the seminal vesicles consistent
with decreased testosterone levels. In the above
mentioned work by Zielenska-Psuja et al. (52),
histological changes in the testes were not seen
after 3 or6 months exposure. Assuming 1% absorp-
tion, the doses given should correspond to absorbed
amounts of 0.05 or 0.50 mg/kg body weight. After
12 or 15 months of exposure a dose-dependent
effect on the testicles was seen with a high propor-
tion of damaged seminiferous tubules in the high
exposure group. (In the paper it is stated that
determination of cadmium has been performed on
the testes and that such data are found in Table 3.
However, no such table is found in the paper). As
mentioned earlier, there was a significant dose-
dependent decrease in serium testosterone levels
during the first 3 months of the study. However,
further exposure caused increases in serum testos-
terone. Thus, after 15 months the testosterone
level was about twice as high in the low exposure
group as in controls, whereas the high exposure
group had the same concentrations as the control
group. Inrats given cadmiumin drinkingwaterata
concentration of 34.4 mg/l. for 6 weeks, with low
and adequate intakes ofzinc, it was found that the
in vitro synthesis of testosterone from progester-
one was more reduced in the cadmium-exposed
group with low intake of zinc, compared to groups
either on a low zinc intake or exposed to cadmium
with an adequate supply of zinc (58).
With regard to human beings, it was reported by
Smith et al. (59) that autopsies ofmen occupational-
ly exposed to cadmium revealed increased concen-
trations of cadmium in prostate and testicles.
Excretion of androgens in urine of cadmium work-
109ers was studied by Favino et al. (60). Ten workers
exposed to cadmium were compared to 10 controls
matched for age. There was no difference between
exposed and controls with regard to excretion of
total17-ketosteroids, androsterone, etiocholanolone
and testosterone. There was a tendency for a
decrease in the excretion ofepitestosterone among
the exposed subjects.
Experimental Carcinogenicity of
Cadmium
Sarcomata at injection sites have been induced in
rats after subcutaneous or intramuscular injections
of cadmium in the form of metal powder, sulfide,
chloride, sulfate or in ferritin contaminated with
large amounts ofcadmium (11-17). The doses given
were large and in some ofthese studies it was also
found that after initial testicular damage tumors
developed in the testes (11, 13-15). It has also been
shown that lower doses, not capable of causing
testicular necrosis, would induce sarcomata at the
injection sites after subcutaneous or intramuscular
injection (18).
In contrast to the dramatic results of injection
studies, long-term studies with mice or rats given
cadmium in drinking water at a concentration of 5
mg/i. did not give any consistent results. More
tumors appeared among cadmium exposed rats,
while the opposite was found among cadmium
exposed mice, as compared to controls (19-21).
In a recent study (28), groups of 50 male or
female rats were given cadmium in drinking water
at concentrations of 3, 10, and 50 mg/i. for two
years. No prostatic tumors were found. There was
nodifference between exposed animals and controls
with regard to malignant tumors in other organs.
Dataon cadmium concentrations inorganswere not
given.
Three studies, especially designed to investigate
the connection between cadmium exposure and
cancer of the prostate have been reported (22, 26,
27). In the first study by Levy et al. (22) rats were
given weekly subcutaneous injections of cadmium
sulfateindosesof0.22, 0.44, and0.87mgCd/ratfor
2 years. There were 25 rats in each exposure group
and 75 in the control group. When the experiment
was terminated after 750 days, between 11 and 17
animalsremained ineach ofthe exposed groups and
32 ofthe controls. During the experimental period,
fouranimals inthe highest exposure group developed
sarcomas at the injection site. One animal from
each of the other exposure groups also developed
sarcomas. Microscopic examination ofprostates did
not disclose any signs ofneoplastic orpreneoplastic
changes in the prostate gland. Slight epithelial
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hyperplasiawas seen tothe same degree in controls
and exposed animals. It should be noted that all
animals inthe twolowest exposure groupswere not
examined. A few tumors in other organs were
observed, both in controls and exposed animals.
There was no consistent pattern of appearance.
Cadmium was analyzed in organs but accurate data
could not be obtained since some tissues had dried
during storage. However, the renal concentrations
of cadmium must have been at least 100 mg/kg
whole kidney in the highest exposure group.
Levy and Clark (26) and Levy et al. (27) gave
rats and mice weekly doses by stomach tube for 2
years. In the rat experiment (26) there were three
exposed groups with 30ratsineach and 90 controls.
Cadmium was given as cadmium sulfate in doses of
0.087, 0.18, and 0.35 mg Cd/kg body weight. The
miceweregiven0.44, 0.88, and 1.75mgCd/kgbody
weight. The number ofmice in each exposed group
was 50 and in the control group 150. At the end of
the experiment, between 8 and 17 rats remained in
the exposed groups and 52 in the control rats,
whereas correspondingfigures forthe mice were 42
to 47 and 125. In neither of the experiments did
histological examination of the prostate gland re-
veal any neoplastic or preneoplastic changes, nor
was there any increased incidence of tumors in
other organs among exposed animals, compared to
controls. Determination of cadmium in rat kidneys
showed that concentrations varied between 2.8 and
10.1 mg/kg, comparable to values found in human
nonsmokers with "normal" exposure to cadmium
(40). Cadmium was not determined in tissues from
mice, but it can be calculated that cadmium concen-
trations in mouse kidneys must have been very low
as well. These low values are explained by the low
absorption of cadmium in rats and mice (1).
Scott and Aughey (61) examined prostate glands
of50 rats given from 1 to 5 subcutaneous injections
of5.6 mgCd as the chloride. The average weight of
the animals was reported to be 70 g, which means
that the given doses should correspond to 80 to 400
mg Cd/kg body weight, i.e., lethal doses. It is not
reported howmanyofthe 50rats died, noris length
of observation time after injections given. Howev-
er, the authors stated that "a possible early adeno-
carcinoma has been found."
When discussing the experimental induction of
cancer ofthe prostate it must be remembered that
the prostate gland in rodents is quite different from
that ofhumans. Monkeys and dogs to some extent
are comparable to humans in that respect, but
there are no data on cadmium effects on the
prostate of these animals. It must also be kept in
mind that while cancer of the prostate is an
extremely common disease in human beings of
Environmental Health Perspectivesadvanced age, the incidence of this cancer is very
low in laboratory animals. An extensive review on
prostaticcarcinomainlaboratoryanimalshasrecently
been published (62). In recent years, adenocarci-
nomas of the prostate have been produced in rats
and it has been suggested that these tumor types
might be suitable as a model for human cancer of
the prostate (63, 64).
Epidemiological Studies on
Cancer Morbidity and Mortality
in Cadmium-Exposed People
The first reports of an increased number of
deaths from cancer ofthe prostate among cadmium
workers came from England, where the mortality
among cadmium workers was examined by Potts
(65). Results from Potts' limited study initiated a
larger investigation by Kipling and Waterhouse in
1967 (23). Cases reported by Potts are included in
the latter study described in the following.
The study comprised 248 men with a minimum
exposure of one year to cadmium oxide dust. It is
mentioned inthis verybriefreportthatthe cause of
death amongthe deceased was ascertained andthat
the expected number of cases of cancer was calcu-
lated by using a regional cancer registry. The
authors stated that the total incidence ofcancer did
not differ between the groups and that there was a
significant increase in the number of prostatic
cancers, four observed cases against an expected
number of 0.58. There was no indication of an
increased risk for bronchial cancer.
Humperdinck reported in 1968 (24) that among
536 German workers employed any time during
1949 to 1966, and exposed to cadmium, there were
five cases of cancer and no apparent relationship
between cadmium exposure and cancer. However,
269 of the workers had been exposed for less than
one year and only four had been exposed for more
than seven years. There was no mention of any
cancer ofthe prostate. Holden in 1969 (25) reported
one case ofcancerofthe prostate among42workers
exposed to cadmium oxide fumes for 2 to 40 years.
Lemen et al. (29) studied mortality in a cohort of
workers occupationally exposed to cadmium oxide
fumes ordust in a smelter. This smelterwas mainly
concerned with the refining of cadmium from
preprocessed ore, which means that concentrations
of other metals or metalloids were relatively low.
In the 1940's, cadmium concentrations in air had
been reported to be several milligrams per cubic
meter, and concentrations measured in 1973 showed
valuesupto 24mg/m3. Generall y, however, concen-
trations were below 1 mg/m . In 1973, arsenic
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concentrations were around 1 ,ug/m3. No data on
arsenic levels in the 1940's are available. The cohort
studied consisted of292 white males, exposed forat
leasttwoyears between 1940 and 1969. In 1974, 180
members ofthe cohort were alive and 92 had died.
Data could not be obtained for the remaining 20
who were considered to be alive. Expected cause-
specific number of deaths were calculated from
statistics for the whole US white male population.
In the cohort, 99 deaths were expected as com-
pared to the 92 observed. In 27 cases the cause of
death was cancer, whereas 17.5 were expected.
There was a significant excess of cancer of the
respiratory tract, SMR being 235, but no data on
somking habits are given. There were four deaths
from cancer of the prostate, as contrasted to 1.15
expected. It could not be proven statistically that
this constituted an increased risk, but when the
time interval from onset ofexposure was taken into
account it could be shown that there was an
increased risk for cancer of the prostate. This
calculation showed four observed, as contrasted to
0.88 expected, 20 years or more after onset of
cadmium exposure. These four cases are presented
in a table which shows that one man who died in
1972 was exposed between 1940 and 1944, when he
was 39 to 43 years old. Nothing is reported about
his occupation before 1940 or after 1944 until
retirement. In the other three cases, the duration
ofexposure was between 13 and 18 years. In two of
these cases exposure began already in the 1920's
and ended in the 1940's. Thus, the main exposure
was during times when no measurements ofcadmi-
um in air or other constituents were undertaken,
but it may be presumed that they were exposed to
high concentrations of airborne cadmium. Unfor-
tunately, no data on arsenic concentrations in the
1920's are available. The authors concluded thatthe
results "implicate cadmium exposure as the cause
of certain types of malignant disease." Another
major study is by Kjellstrom et al. (33). In the
battery factory described by Friberg (42) all work-
ers alive in 1959 were studied. They had more than
five years of exposure and had been employed in
1945 or started working after that year. The
changes in exposure since 1945, when cadmium
concentrations in air were several mg Cd/m3 have
been reported (37, 43) and the present exposure is
generally less than 15 ptg/m3 (38). Many workers
had already started work in the 1920's but no
exposure data are available from this time. The
workers had also been exposed to considerable
amounts of nickel hydroxide dust. All workers
diagnosedashavingcancerduringtheyears 1959-1975
were identified in the Swedish Cancer Registry. Of
269 male workers born between 1874 and 1952, 15
111cases ofcancerhad been diagnosed. Itwas calculat-
ed from the national incidence rates that 16.4 new
cases would have occurred. With regard to specific
causes, no significant increase could be found ex-
cept for cancer of the nasal pharynx. Two cases
were found, whereas only 0.2 were expected. This
was thought to be caused by nickel exposure. Two
prostatic cancers were found, while 1.2 were
expected. The corresponding figures for lung can-
cer were 2 and 1.35. Five cancers of the colon or
rectum were found against 2.25 expected.
Kjellstrom et al. also investigated a cadmium-
copper alloy plant, where the workers had been
exposed to cadmium oxide fumes. In that factory
cadmium in airwas not determined untilthe middle
ofthe 1960's, when concentrations were 100 to 400
,ug Cd/m3. Present exposure levels are lower.
Workers who had been employed in 1940 or started
work after that year and with at least five years of
exposure, were studied. In this study the prostatic
cancer deaths among 94 exposed men were com-
pared to prostatic cancer deaths among 328 work-
ers employed in the same factory but in another
type of production. Expected numbers of death of
cancer ofthe prostate were calculated from reports
from the Swedish National Bureau of Statistics.
Among the cadmium exposed workers, four cases
were observed against 2.69 expected, and in the
reference group, four were observed as compared
to 6.42 expected. Thus, in these two studies there
was also a tendency to an increase of prostatic
cancers among cadmium exposed workers. Howev-
er, it could not be statistically proven that there
was a real difference.
There are two other studies (30, 31) which have
been extensively quoted in the literature as evi-
dence for cadmium causing renal cancer and pros-
tate cancer, respectively. There are, however, no
data at all on cadmium exposure in these reports.
The Prostate
Physiology, Biochemistry, and
Metal Metabolism
The development and growth of the prostate, a
genital accessory gland, is regulated by hormones.
Figure 1 shows some of the more important endo-
crine glands and their influence on the prostate. An
important factor is testosterone, which is produced
in the testes. Testosterone production is in turn
stimulated by pituitary hormones, especially LH.
There may also be a direct pituitary influence
through prolactin, which is thought to regulate the
uptake of androgens in the prostate. Also the
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FIGURE 1. Major hormonal influences on the prostate.
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FIGURE 2. Cadmium and zinc concentrations in normal
prostates (73).
adrenal androgens may have an influence. Among
the metals, zinc is outstanding. The highest concen-
trations are found in seminal plasma and the
prostate (66-74). Zinc uptake has also been shown
to be regulated by hormones (75, 76). There are
large differences in zinc concentrations within the
prostate. Intraglandular variations are larger than
interglandular (70). Zinc is mainly localized in the
epithelial cells (74). It has been shown in rats that
great cyclic variations in uptake of zinc may occur
(75-77). Zinc is eliminated from the prostate via
seminal fluid and is of importance for the viability
motility, and fertility of human spermatozoa (67,
68, 78, 79).
Zincandcadmiumconcentrations innormalhuman
tissue according to age are shown in Figure 2. The
Environmental Health Perspectivesdata are from a study by Heinzsch et al. (73). A
relationship between zinc and cadmium concentra-
tions in prostatic tissue was reported by Habib (80).
However, it has earlier been claimed by the same
author that there were no correlations between
cadmium and zinc in hypertrophic or carcinomatous
tissues (71). Figures 3 and 4 show the relationship
between prostatic cadmium and renal and liver
cadmium [data taken from Hienzsch et al. (73) and
Anke et al. (81)].
Data used for construction of Figures 2 to 4 are
shown in Table 1, together with data from other
studies where cadmium in the prostate and in the
testicles has been determined. Heinzsch et al. (73)
included their cases above 50 years of age among
the "normals" though probably a very large propor-
tion of these men have had prostatic hypertrophy.
It is not possible to draw any clear conclusions
about the cadmium levels in different diseases of
the prostate from the available data. The few data
available on testicular cadmium in normal people
indicate that the level in this organ will be of the
same magnitude as in the prostate. Regarding
excessive exposure to cadmium there is one case
with heavy environmental exposure to cadmium
(84) and three occupationally exposed men (59).
Prostatic cadmium as well as testicular cadmium
had reached high concentrations and again there is
an indication that testicular concentrations will be
ofthe same magnitude as prostatic concentrations.
Also animal data indicate that there is a parallel
accumulation in the prostate and in the testicles.
Nordberg (55) found in mice given 0.25 mg Cd/kg
subcutaneously 5 days a week during 6 months that
the average concentration of cadmium in the pros-
tate was 5.44 and in the testicles 4.45 mg/kg wet
weight. In mice given the double dose, the concen-
trations were 11.45 and 8.23 mg/kg, respectively.
Epidemiology of Cancer of the Prostate
Cancer ofthe prostate is one ofthe most common
causes of death from cancer, especially in some
European countries and in the USA. It has thus
attracted great interest and initiated a large num-
ber ofreviews and epidemioliogical studies (85-107).
As for other forms of cancer, there have been
changes in the diagnosis and classification of the
disease, and changes in incidence sometimes have
been difficult to evaluate. The disease is very rare
in menunderage 50, and it is strongly influenced by
hormonal status since it does not develop in men
castrated before age 40. There are large differences
between countries with regard to the occurrence of
the disease. Thus the non-white population in the
U.S. and Sweden have among the highest death
rates of cancer of the prostate, whereas Japan has
among the lowest (85). Cancer of the prostate
without clinical manifestations, latent prostatic car-
cinoma, is as common inJapanese living inJapan as
inJapanese living in the U.S. (Hawaii) (86), where-
as the mortality from cancer ofthe prostate among
Japanese in the U.S. (Hawaii) is higher than in
Japan. This is an important fact to remember, since
exposure to cadmium in Japan is considerably
higher than in both the USA and Sweden. This
indicates that "normal" exposure to cadmium is of
little importance for the development ofthe clinical
manifestations ofcancer ofthe prostate. However,
as will be discussed later, this does not exclude the
possibility that extreme exposure to cadmium might
have an influence.
The occurrence of latent carcinoma in seven
areas around the world was studied by Breslow et
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FIGURE 3. Cadmiurn in prostate in relation to liver cad-
mium (73,81).
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1-Table 1. Cadmium and zinc in prostate and cadmium in kidney, liver and testicles from normal men (N), men with benign
prostatic hyperthrophy (BPH), cancer of the prostate (CaP), men exposed to cadmium in the general environment (E) and
occupationally exposed men (0).
Metal conen (mg/kg dry weight)
Prostate Kidney Liver Testicles Ref.
Age n Cd Zn Cd Cd Cd
N 1 10 0.26 183 1.3 0.67 (73)
2-5 10 0.72 160 5.4 1.1 (73)
6-10 10 0.61 167 15 2.0 (73)
11-20 10 0.65 238 18 2.0 (73)
21-30 10 1.3 396 29 2.6 (73)
31-40 10 1.8 311 55 6.0 (73)
41-50 10 2.1 310 92 7.9 (73)
51-60 10 3.0 485 78 5.9 (73)
61-70 10 2.1 520 96 6.9 (73)
71-80 10 2.1 456 62 6.0 (73)
81-90 10 1.8 419 27 4.9 (73)
40-70 17 70 10 2.3 (81)
40-80 20 133 13 4.1 (81)
36 9 0.58 445 (71)
10-60 15 180 11 2.6 (83)
49 1 0.90 40 7 0.95 (59)
56 1 0.85 47 7 0.8 (59)
56 1 0.50 60 10 1.0 (59)
BPH 41-90 1.1 (73)
70 23 2.58 449 (71)
? 15 0.61a 555 (80)
CaP 41-90 ? 0.62 (73)
73 9 14.5 170 (71)
E 83 1 270 317 70 (84)
0 46 1 185 500 550 170 (59)
55 1 90 1200 1035 45 (59)
67 1 550 224 3.5 (59)
a Calculated from Habib (80).
al. (87). Consecutive autopsies were made of per-
sons without clinical signs of prostatic cancer.
Standardized methods were used to obtain speci-
mens from the same parts of the prostate. Micro-
scopic examination was made by the original
pathologist and on a blind basis by other participat-
ing pathologists. Carcinomas were classified as
small, medium or large. Small carcinomas occurred
in about 12 percent of all cases and did not vary
with area or with age. Medium and large latent
carcinomas were common in Sweden, West Ger-
man, andJamaica (26.8, 18.5, and 17.9%) whereas a
low frequency was found in Hong Kong, Israel, and
Singapore (6.9, 5.6, and 5.0%). In Uganda the
frequency was 10%. There was increase with age,
occurring on an average of 4.6% in the age group
45-54 and 28.7% in the age group 75 years and over.
The frequencies correspond to the mortality from
prostatic cancer in the studied areas. This study
indicates that the inducing factor occurs to the
same extent in many areas, but that promoting
factors may vary to a large extent.
In a recent study by Holund (88) latent cancer of
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the prostate was found on in about 22% ofa series
ofconsecutive autopsies in Denmark. The frequen-
cywas 10% inagegroup 50-59 and26% inagegroup
70-79.
In addition to the earlier mentioned studies on
prostatic cancer among cadmium exposed workers,
there aremanystudies where otherfactorsthought
to be ofimportance for cancer ofthe prostate have
been investigated. Among such factors are occupa-
tion, race, sex life, socioeconomic status, and nutri-
tion.
In 1931, the relationship between cancer of the
prostate and certain occupations was studied (89).
Henry et al. studied cancer of the bladder and
cancer ofthe prostate, and whereas they could find
that cancer of the bladder was related to certain
occupations, no consistent pattern appeared with
regard to cancer of the prostate. A study of more
historicalinterestwaspublishedin 1949byVersluys
(90) who reported data on cancerin the Netherlands
during the years 1931-1935. In that study it was
found that people with university education, espe-
cially clergymen, had an increased incidence of
Environmental Health Perspectivescancer of the prostate. In later years there have
been several studies on rubber workers (31, 91-93)
but no consistent pattern has appeared with regard
to cancer of the prostate and when an excess of
prostatic cancers was found, exposure to cadmium
could not be demonstrated (93, 94). Metal workers
were examined by Houten et al. (95). Blacksmiths,
mechanics, andrepairmen showed, accordingtothe
authors, significantly elevated risks for cancer of
the prostate. In the group "furnace-men, smelter-
men and pourers" there did not seem to be an
increased risk for cancer ofthe prostate. In several
other occupations where exposure to metals might
have occurred, such as mine workers, the relative
risk seemed to be increased but not significant.
A recent study designed especially to study the
relationship between prostatic cancer and occupa-
tion was reported by Ernster et al. (94). They
studied deaths ofprostatic cancer in two California
counties using the case-control method. In the two
counties, 368 and 334 prostatic cancer deaths were
found. Matching was done for age and race. The
authors concentrated on occupations where elevat-
ed numbers were seen in both counties. A broad
occupational spectrum was found. Bookkeepers,
shipping and receiving clerks, compositors and
type-setters and ship-fitters were found to have an
increased risk. Persons working in fields such as
horticultural services, newspaper publishing and
printing, motor vehicle sales, drug-stores, drugs,
chemicals and allied products, as well as miscella-
neous personal services showed elevated incidence
ofcancer ofthe prostate. These results indicate, as
well as earlier mentioned studies, that there is no
consistent pattern for cancer of the prostate with
regard to occupation.
Another major study is by Williams et al. (96)
who used data from the Third National Cancer
Survey Interview in the USA. They studied cancer
patients who had been interviewed and about
whom extensive information on occupation could be
obtained. In that study, it was found that prostate
cancer was more common among ministers, farn-
ers, plumbers, rubber workers, coal miners and
two types ofretailers. This once again indicates the
broad spectrum of occupations where an excess
might be found. The following is a quote from the
report: "A positive association between prostate
cancer and men working for non-profit organiza-
tions was localized entirely to older men who were
well educated nonsmokers and nondrinkers (proba-
bly the clergymen found associated in the analysis
of occupation)." It was earlier mentioned that
results from a study in the Netherlands (87) indi-
cated that clergymen had an increased risk for
developing cancer ofthe prostate. In this context it
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is also of interest to mention that among active
Mormons (men who live according to the "Word of
Wisdom") the mortality from most types of cancer
forms unrelated to smoking is much lower than for
nonsmoking white males in the U.S. One exception
is cancer of the prostate, which was the most
common cancer among active Mormon males in
Utah (97). In fact, intake of alcohol might have a
protective effect, since the incidence of prostatic
cancer is lower among patients with liver cirrhosis.
A decreased breakdown of estrogen is thought to
be the reason forthis finding (85). Alcohol may also
have a direct effect on the production oftestoster-
one in the testes (98-100). The metabolite, acetal-
dehyde, can also have an influence (99).
Cancer mortality among printers has been stud-
ied by Green et al. (101) who found an excess only
among non-white printers. This was a proportion-
ate mortality study, and it is difficult to compare
with earlier mentioned studies. In some of the
earlier papers (87, 94) printers seemed to have an
increased risk for cancer of the prostate. It was
statedthattherewasnoassociationbetweenprostatic
cancer and cadmium exposure, but it is not clear
whether cadmium concentrations in air were de-
termined. In two studies on ferrochromium work-
ers in Norway and Sweden (102, 103) a slight
increase was found in the incidence of prostatic
cancer. Espeically maintenance workers showed an
excess.
The relationship between marital status and
cancer of the prostate has been investigated in
several studies. Thus, Versluys (90) concluded that
canceroftheprostate was found more frequently in
married people and those who had been married.
Lancaster (104) found in Australia that cancer of
the prostate was more commonamongmarried men
with children than among married men without
children or men who had nevermarried. King et al.
(105) in an extensive review on the epidemiology of
cancer ofthe prostate concluded: "Persons who had
ever married have a higher frequency of cancer of
male genital organs than those who remained
single." According to King et al., cancer of the
prostate is the form of cancer which in both white
and nonwhite shows the highest ratio of ever-
married males to single males. Among the ever
married men it was also indicated that there was a
higher mortality among the widowed and divorced
men.
Greenwald et al. (106) studied the relationship
between widowerhood and cancer of the prostate
and concluded that earlier data, showing higher
rates ofprostate cancer among widowers, might be
influenced by artefacts of classifying in vital re-
cords. Furthermore, Greenwald et al. (107) did notfind that martial status was a factor of importance
in the development of cancer ofthe prostate. Even
though a statistical significance was not obtained in
that study, there was an indication among the
prostate cancer patients of a lower number without
children than among controls.
In addition to marital status attempts have also
been made to relate sexual activity and habits to
cancer of the prostate (108, 109). In one of these
studies (108) it was claimed that delayed sexual
development might be one factor ofimportance for
the development of prostatic cancer and that early
repression of sexuality and premature cessation of
sexuality also could contribute. However, in this
study it was also reported that occupational expo-
sure to fertilizers and auto exhaust fumes were
more common amongprostatic cancerpatients than
among controls.
Marital status and cancer was also studied by
Ernster et al. (110) using data from the Third
National Cancer Survey. With regard to prostatic
cancer they found that single men had lower
incidence rates than married men who in turn had
lower rates than widowers. It was also found that
married persons generally had low rates for death
from all causes combined.
That race might be a factor has already been
mentioned. In the U.S. the mortality rate for
nonwhites has increased markedly during the last
decades and is now considerably higher than among
the whites (111-115). This difference is thought not
to depend on socioeconomic factors (111). Black
populations in Africa and the West Indies have
lower prostatic cancer mortality rates than U.S.
blacks (85, 112). Death from cancer ofthe prostate
is uncommon inJapan, but it should be kept in mind
thatinJapan there has been anincrease inprostatic
cancer mortality from about 0.5/100,000 to about
2/100,000 from 1950 to 1963, a 4-fold increase.
During the same period, the rate increased from
about17/100,000 amongU.S. nonwhitesto22/100,000
and showed a slight decrease from about 13/100,000
to 11/100,000 among U.S. whites. In Sweden, the
corresponding figures were about 12 and 18/100,000
(86). In a recent study (113) it was shown that
amongJapanese living in two counties in California,
prostatic cancer constituted about 14 and 3.5% of
total cancer deaths, respectively, whereas the
corresponding figure in Japan is less than 1%. In
the same study it was also found that Chinese in
California had lower incidence of prostatic cancer
than U.S. whites, the figures being similar to the
Japanese in USA.
In the U.S., cancer of the prostate is more
common in counties where Scandinavian descen-
dants reside (115). The higher incidence among
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U.S. blacks has also been related to population
density (105, 115). Otherwise, regional differences
in the U.S. are relative small. Among the whites
there was only an 8% difference between regions
with the lowest and the highest mortality rates
(115).
Religion has also been implied as a factor (85,
105), Protestants in the U.S. having a higher death
rate than Catholics andJews (105). Dietary factors,
especially intake of fat, must also be taken into
account (16). Hill et al. (117) gave black South
African men, who ordinarly had a vegetarian diet, a
Western diet high in fat and animal protein for 3
weeks. Black and white North American men,
ordinarily on aWestern diet, were given a vegetar-
ian diet for 3 weeks. Urinary excretion of andro-
gens and estrogens before the experimental diet
was found to be much lower in the South African
men than in black or white Americans. The experi-
mental diets caused an increase in the excretion of
androgens and estrogens of the black South Afri-
cans and a decrease among the black and white
North Americans. These data give strong support
that diet is a main factor and that the racial
differences in mortality from prostatic cancer to a
large extent depend on the dietary habits. It is,
however, not clear if this can fully explain the
difference between the whites and the blacks in the
U.S.
There are still other factors which could be
discussed, but the above mentioned data may
indicate the extreme complexicity ofthe etiology of
cancer ofthe prostate and how incomplete present
knowledge is. Even the Kinsey report has been
quoted (105) as giving clues to the etiology.
Can Cadmium Induce Cancer
of the Prostate?
The fact that the frequency of small latent
cancers is about the same in countries with large
differences in deaths from prostatic cancer indi-
cates that males all over the world probably have
the same chance of developing this type of cancer.
Exogenous and endogenous factors, e.g. nutrition,
sex life, and liver function, will then decide to what
extent the cancer becomes clinically manifest.
If low level exposure to cadmium is a factor for
inducing the cancer, it could be expected that the
latentcancerwouldbemorecommonamongJapanese
in Japan, whereas Japanese in the US would have
less. In fact the prevalence is the same. This does
not mean that excessive occupational exposure may
not induce prostatic cancer, rather that it may not
be right to extrapolate from data obtained in
occupational studies to "normal" exposure levels.
Environmental Health PerspectivesTheoretically, cadmium can influence the pros-
tate in several ways. As previously mentioned,
high cadmium concentrations have been found in
prostates of men exposed to excessive amounts of
cadmium. A direct interaction with zinc is thus
possible. It has been demonstrated that in
carcinomatous prostatic tissues there are increased
levels oftestosterone and androstenodione whereas
dehydrotestosterone levels aredecreased (118, 119).
In a brief report (120) it was stated that a zinc-
binding protein, similar to metallothionein, was
found in normal and hypertrophic prostatic tissue.
This protein was claimed to have some affinity for
androgens. The authors speculated that a slight
shift in the hormone/metal balance may induce
cancer of the prostate. Wallace and Grant (121)
have postulated that when epithelial cells in the
prostate are saturated with zinc, this will stop the
reduction of testosterone to dehydrotestosterone
by thiol groups. When zinc is lost via seminal fluid,
the activity of 5-a-reductase is restored. Dehydro-
testosterone is again produced and this will in turn
stimulate new incorporation of zinc in the cells.
Theoretically, accumulation ofcadmium could cause
permanent binding of thiol groups and thus cause
an accumulation oftestosterone which could induce
orpromote cancer. Accumulation ofcadmium in the
testes, on the other hand, might decrease testos-
terone levels, which theoretically would have a
protective effect. Another possibility is that accu-
mulation of cadmium in the pituitary gland could
cause changes in prolactin and LH production.
The accumulation ofcadmium in liver and kidney
causes an accumulation ofzinc in these organs and
it has been shown in animal experiments that ifthe
zinc intake is marginal, cadmium exposure will
cause a decrease in testicular concentration ofzinc
(122) as well as decreased testosterone production
(58). There are no data on prostatic concentrations
of zinc in cadmium exposed animals or humans.
However, the intake of zinc is marginal for many
humans and it is conceivable that in heavily ex-
posed cadmium workers a relative zinc deficiency
may exist which together with accumulation of
cadmium might contribute to the theoretical mech-
anisms explained above.
All reported cases ofexcess deaths from prostatic
cancer among cadmium exposed workers refer to
workers with heavy exposure. It is conceivable that
both high prostatic cadmium concentration and a
disturbed zinc metabolism may have existed in
these workers. In these studies no attention has
been paid to the other factors mentioned in the
context of the general epidemiology of prostatic
cancer. Martial status, fertility, sexual habits,
nutrition etc. should be taken into account in
further studies on occupationally exposed workers.
Even ifthere is a higher incidence ofdeaths from
prostatic cancer among heavily exposed workers it
does not seem reasonable to extrapolate to low
level exposure. If there is a cancer-promoting
action from large doses of cadmium, it is probably
indirect, mediated through the hormonal systems
regulating metabolism of prostatic cells.
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